Evidence map›Paper›PMID 39779848›Full record

ArticleNature2025

Saturation genome editing-based clinical classification of BRCA2 variants.

Sounak Sahu, Melissa Galloux, Eileen Southon, Dylan Caylor, Teresa Sullivan, Matteo Arnaudi, Maria Zanti, Josephine Geh, Raj Chari, Kyriaki Michailidou and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Reclassification ofCurrent oncology (Toronto, Ont.) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Comprehensive evidence for the pathogenicity of theJournal of medical genetics · 2026
    Article
  10. Phenotype-Specific Recalibration of MAVE Data Enables Repurposing ofmedRxiv : the preprint server for health sciences · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Saturation Genome Editing TargetingCurrent issues in molecular biology · 2026
    Article
  16. Cancer genomic profiling predicts pathogenicity ofmedRxiv : the preprint server for health sciences · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sounak SahuMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0001-7290-6651
Melissa GallouxIndependent bioinformatician, Marseille, France.ORCID 0009-0009-4424-6815
Eileen Southon *Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Dylan Caylor *Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Teresa SullivanMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0001-8771-9066
Matteo ArnaudiCancer Systems Biology, Section for Bioinformatics, Department of Health and Technology, Technical University of Denmark, Lyngby, Denmark.
Maria ZantiBiostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.ORCID 0000-0002-0136-9921
Josephine GehMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Raj ChariGenome Modification Core, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-2216-313X
Kyriaki MichailidouBiostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.ORCID 0000-0001-7065-1237
Elena PapaleoCancer Systems Biology, Section for Bioinformatics, Department of Health and Technology, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0002-7376-5894
Shyam K SharanMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. sharans@mail.nih.gov.ORCID 0000-0002-9333-870X

Funding

NCI NIH HHS HHSN261201500003INCI NIH HHS K99 CA279648
6 · The paper itself

Abstract

Sequencing-based genetic tests have uncovered a vast array of BRCA2 sequence variants

Indexed as

BRCA2 ProteinGene EditingPolymorphism, Single NucleotideAnimalsCell LineCRISPR-Cas SystemsExonsFemaleHumansMiceMutation, MissenseBRCA2 ProteinBRCA2 protein, human

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.